Stance Capital’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.77K Buy
+811
New +$2.73K ﹤0.01% 270
2025
Q4
Sell
-2,733
Closed -$19K 143
2025
Q3
$19K Buy
+2,733
New +$19.3K 0.01% 231
2025
Q1
Sell
-2,889
Closed -$34.3K 66
2024
Q4
$34.3K Buy
+2,889
New +$49.2K 0.02% 152

Other funds holding ASPN

Stance Capital's ASPN Position: Q1 2026 in Review

Stance Capital opened a new position in Aspen Aerogels (ASPN) in Q1 2026: 811 shares worth $2.77K. The stake represents ﹤0.01% of the portfolio and ranks #270 among its holdings. This is a return to the name: Stance Capital previously reported a position in ASPN as recently as Q3 2025.

Stance Capital first reported a position in ASPN in Q4 2024 and has held it in 3 quarters since. The position peaked at $34.3K in Q4 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Stance Capital held 811 shares of Aspen Aerogels worth $2.77K as of Q1 2026.
  • Aspen Aerogels was a new Stance Capital position in Q1 2026.
  • Aspen Aerogels made up ﹤0.01% of Stance Capital's portfolio in Q1 2026, its #270 holding.
  • Stance Capital first reported a position in Aspen Aerogels in Q4 2024 and has held it in 3 quarters since.
  • Stance Capital's Aspen Aerogels position peaked at $34.3K in Q4 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Stance Capital's 13F filing for Q1 2026, filed 14 May 2026.